$2.72T
Total marketcap
$93.09B
Total volume
BTC 49.74%     ETH 16.99%
Dominance

BB Biotech AG BBZA.DE Stock

41 EUR {{ price }} -0.606061% {{change_pct}}%
COUNTRY
Germany
Exchange
XETRA
Market Cap
2.25B EUR
LOW - HIGH [24H]
40.55 - 41.2 EUR
VOLUME [24H]
23.83K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-3.8 EUR

BB Biotech AG Price Chart

BB Biotech AG BBZA.DE Financial and Trading Overview

BB Biotech AG stock price 41 EUR
Previous Close 43.9 EUR
Open 44.2 EUR
Bid 44.4 EUR x 28900
Ask 44.5 EUR x 36300
Day's Range 44.2 - 44.5 EUR
52 Week Range 42.5 - 65.6 EUR
Volume 4.22K EUR
Avg. Volume 19.36K EUR
Market Cap 2.44B EUR
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -3.8 EUR
Forward Dividend & Yield 2.86 (6.70%)
Ex-Dividend Date March 27, 2023
1y Target Est 84.9 EUR

BBZA.DE Valuation Measures

Enterprise Value 2.39B EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.9065665
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

BB Biotech AG Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -15.25%
S&P500 52-Week Change 20.43%
52 Week High 65.6 EUR
52 Week Low 42.5 EUR
50-Day Moving Average 46.38 EUR
200-Day Moving Average 54.09 EUR

BBZA.DE Share Statistics

Avg. Volume (3 month) 19.36K EUR
Avg. Daily Volume (10-Days) 29.92K EUR
Shares Outstanding 54.85M
Float N/A
Short Ratio N/A
% Held by Insiders 1.76%
% Held by Institutions 7.75%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) 0 EUR
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 4K EUR
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -6.83
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 48.976

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of BB Biotech AG

Country Germany
State N/A
City Kusnacht
Address Seestrasse 16
ZIP 8700
Phone 41 44 267 67 00
Website https://www.bbbiotech.ch/en/bb-biotech/
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 10

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Q&A For BB Biotech AG Stock

What is a current BBZA.DE stock price?

BB Biotech AG BBZA.DE stock price today per share is 41 EUR.

How to purchase BB Biotech AG stock?

You can buy BBZA.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BB Biotech AG?

The stock symbol or ticker of BB Biotech AG is BBZA.DE.

Which industry does the BB Biotech AG company belong to?

The BB Biotech AG industry is Biotechnology.

How many shares does BB Biotech AG have in circulation?

The max supply of BB Biotech AG shares is 54.85M.

What is BB Biotech AG Price to Earnings Ratio (PE Ratio)?

BB Biotech AG PE Ratio is now.

What was BB Biotech AG earnings per share over the trailing 12 months (TTM)?

BB Biotech AG EPS is -3.8 EUR over the trailing 12 months.

Which sector does the BB Biotech AG company belong to?

The BB Biotech AG sector is Healthcare.